Supernus Pharmaceuticals (SUPN) Return on Sales (2011 - 2025)

Supernus Pharmaceuticals (SUPN) has 15 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2025; TTM through Dec 2025 was 0.0%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for SUPN reached as high as 0.0% in Q3 2024 and fell as low as 0.0% in Q3 2025.
• Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
• On a YoY basis, Return on Sales climbed as much as 0 bps in 2021 and fell as far as 0 bps in 2021.
• Year by year, Return on Sales stood at 0.0% in 2021, then surged by 893 bps to 0.0% in 2022, then sank by 95 bps to 0.0% in 2023, then surged by 1131 bps to 0.0% in 2024, then slumped by 122 bps to 0.0% in 2025.
• Per Business Quant data, the three most recent Return on Sales figures were 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.